Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody

Activating mutations in fibroblast growth factor receptor 3 (FGFR3) have been identified in multiple types of human cancer and in congenital birth defects. In human lung cancer, fibroblast growth factor 9 (FGF9), a high-affinity ligand for FGFR3, is overexpressed in 10% of primary resected non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yongjun, Ren, Xiaodi, Smith, Craig, Guo, Qianxu, Malabunga, Maria, Guernah, Ilhem, Zhang, Yiwei, Shen, Juqun, Sun, Haijun, Chehab, Nabil, Loizos, Nick, Ludwig, Dale L., Ornitz, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892666/
https://www.ncbi.nlm.nih.gov/pubmed/27056048
http://dx.doi.org/10.1242/dmm.024760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892666/
https://www.ncbi.nlm.nih.gov/pubmed/27056048
http://dx.doi.org/10.1242/dmm.024760

Ejemplares similares